Top Page
Tate & Lyle
(LSE:TATE)
Tate & Lyle (TATE) vs. iShares MSCI United Kingdom ETF (EWC)
Tate & Lyle Business Overview & Revenue Model
Tate & Lyle Earnings Call Summary
Tate & Lyle Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.56B | 1.74B | 1.65B | 1.75B | 1.38B | 1.21B |
| Gross Profit | 1.56B | 706.00M | 851.00M | 733.00M | 514.00M | 481.00M |
| EBITDA | 338.00M | 254.00M | 345.00M | 279.00M | 168.00M | 292.00M |
| Net Income | 251.00M | 143.00M | 188.00M | 190.00M | 236.00M | 253.00M |
Balance Sheet | ||||||
| Total Assets | 2.21B | 3.73B | 2.28B | 2.51B | 3.25B | 2.97B |
| Cash, Cash Equivalents and Short-Term Investments | 594.00M | 334.00M | 437.00M | 475.00M | 112.00M | 371.00M |
| Total Debt | 555.00M | 1.31B | 590.00M | 713.00M | 679.00M | 786.00M |
| Total Liabilities | 1.02B | 2.14B | 1.04B | 1.32B | 1.63B | 1.51B |
| Stockholders Equity | 1.19B | 1.59B | 1.24B | 1.19B | 1.62B | 1.45B |
Cash Flow | ||||||
| Free Cash Flow | 171.00M | 43.00M | 98.00M | -12.00M | -45.00M | 217.00M |
| Operating Cash Flow | 282.00M | 164.00M | 208.00M | 66.00M | 103.00M | 369.00M |
| Investing Cash Flow | 176.00M | -630.00M | -20.00M | 835.00M | -113.00M | -205.00M |
| Financing Cash Flow | -154.00M | 367.00M | -215.00M | -598.00M | -247.00M | -29.00M |
Tate & Lyle Technical Analysis
Tate & Lyle Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | 2.68B | 20.35 | 13.59% | 2.02% | 4.77% | 18.94% | |
69 Neutral | 1.66B | 13.11 | 8.66% | 1.46% | 1.01% | 11.12% | |
67 Neutral | £2.21B | 35.85 | 3.39% | 3.96% | 5.40% | -67.46% | |
66 Neutral | 586.12M | 15.18 | 12.82% | 5.28% | 8.58% | -15.81% | |
65 Neutral | 14.08B | 11.12 | 13.01% | 3.18% | -0.38% | 14.68% | |
64 Neutral | 1.04B | 19.82 | 10.28% | 0.83% | 0.49% | 14.18% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
Tate & Lyle Corporate Events
Tate & Lyle PLC announced a transaction involving Glenn Fish, a Non-executive Director, who acquired 89.424 American Depositary Receipts (ADRs) at a price of US$29.31 each, representing an interest in 16,199.3 shares of the company. This transaction, conducted on the OTCQX exchange, reflects managerial confidence in the company’s prospects and complies with the Market Abuse Regulation, potentially impacting stakeholder perceptions positively.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC announced a transaction involving Claudia Vaz de Lestapis, a non-executive director, and Alexandre Samuel Pierre Marie de Lestapis, who acquired 2,500 American Depositary Receipts (ADRs) at a price of $28.84 each, representing an interest in 10,000 ordinary shares of the company. This transaction, conducted on the OTCQX exchange, reflects the ongoing engagement of key company figures in its financial instruments, potentially signaling confidence in the company’s market position and future prospects.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC has announced its issued share capital as of July 31, 2025, consisting of 476,739,802 ordinary shares, with 31,294,579 held in Treasury and not carrying voting rights. The total number of voting rights available is 445,445,223, which shareholders can use to determine their interest in the company under the Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:TATE) stock is a Buy with a £1000.00 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
At the 2025 Annual General Meeting, Tate & Lyle PLC announced that all proposed resolutions were passed, including the approval of the Directors’ Remuneration Policy and Report. Notably, 24.19% of shareholders voted against the Directors’ Remuneration Report, prompting the Board to engage further with shareholders to address concerns. The company will provide an update within six months, aligning with the UK Corporate Governance Code.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC announced that Sarah Kuijlaars, the Chief Financial Officer, has acquired 15,000 ordinary shares at a price of £5.185 each, increasing her total holding to 70,000 shares. This transaction, conducted on the London Stock Exchange, aligns with the Market Abuse Regulation requirements and reflects confidence in the company’s future prospects.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC hosted a Capital Markets event in London to discuss its strategy and growth opportunities, emphasizing its role in the future of food. The event highlighted the company’s expanded portfolio and capabilities, including the integration with CP Kelco, which enhances its solutions offering. The company aims to accelerate top-line growth by addressing societal trends and investing in new technologies. The event did not provide new financial updates but showcased the company’s focus on healthier, more sustainable food solutions.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC, a UK-based company, has announced a change in the voting rights held by BlackRock, Inc., an American multinational investment management corporation. BlackRock’s voting rights in Tate & Lyle have fallen below 5%, indicating a reduction in their stake in the company. This adjustment in BlackRock’s holdings may impact Tate & Lyle’s shareholder dynamics and influence within the market.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC has announced the grant of awards over ordinary shares as part of its Performance Share Plan 2020 to key managerial personnel, including CEO Nick Hampton and CFO Sarah Kuijlaars. These conditional awards are contingent on meeting specific performance criteria over a three-year period, reflecting the company’s commitment to aligning management incentives with long-term performance goals.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC has announced the availability of its Annual Financial Report and the Notice of its Annual General Meeting (AGM) for 2025. The AGM is scheduled to take place on July 24, 2025, at the Royal College of Nursing in London. These documents have been submitted to the National Storage Mechanism and are accessible on the company’s website. This announcement ensures transparency and keeps shareholders informed of the company’s financial status and upcoming governance activities, reinforcing Tate & Lyle’s commitment to stakeholder engagement and regulatory compliance.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC announced a transaction involving its Chief Executive, Nick Hampton, who acquired shares under the company’s Group Bonus Plan and Performance Share Plan. The transaction reflects the fulfillment of employment and performance conditions tied to these plans, impacting the executive’s shareholding in the company. This development underscores the company’s adherence to regulatory requirements and its commitment to aligning executive compensation with performance metrics.
The most recent analyst rating on (GB:TATE) stock is a Buy with a £1000.00 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC announced its issued share capital as of May 30, 2025, totaling 476,739,452 ordinary shares, with 31,294,579 held in treasury and not carrying voting rights. This results in 445,444,873 voting rights, a figure that shareholders can use to assess their interest in the company under regulatory rules, potentially impacting shareholder notifications and transparency obligations.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC announced that Sarah Kuijlaars, the Chief Financial Officer, acquired 15,000 ordinary shares at £5.62498 each, totaling £84,374.70, on May 28, 2025. This transaction, conducted on the London Stock Exchange, increases her total shareholding to 55,000 shares, reflecting confidence in the company’s market position and future prospects.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC announced a transaction involving the purchase of American Depositary Receipts (ADRs) by the Kimberly A Nelson Revocable Trust, a person closely associated with Kimberly A. Nelson, a director of the company. The transaction, which took place on May 23, 2025, involved the acquisition of 250 ADRs at a price of $30.40 each, representing an interest in 1,642 ADRs or 6,568 ordinary shares. This notification complies with the Market Abuse Regulation and reflects the company’s commitment to transparency in its managerial transactions.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £7.25 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Tate & Lyle PLC announced that its CEO, Nick Hampton, has exercised options to acquire 3,321 ordinary shares under the Tate & Lyle 2020 Sharesave Scheme at a price of 542 pence per share. This transaction, conducted outside a trading venue, reflects the company’s adherence to the Market Abuse Regulation and highlights the CEO’s continued investment in the company, potentially signaling confidence in its future performance.
The most recent analyst rating on (GB:TATE) stock is a Hold with a £8.20 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.